药品信息的法律保护问题研究

发布时间：2018-04-26 13:05

本文选题：药品信息 + 商业秘密　；参考：《南昌大学》2017年硕士论文

【摘要】：随着成功“入世”和知识经济时代的来临,我国对知识产权的重视程度相应加大。药品领域的知识产权保护问题受到越来越多的关注。药品生产企业的蓬勃崛起离不开药品的信息保护。我国对药品信息保护问题规定的相关法律法规还不健全。将关系公众生命健康的知情权纳入商业秘密研究范畴,不仅有利于保护公共健康,还有利于后续创新的维持。在追求药品产业化的同时如何从权利角度分析药品的信息保护问题,对于保护公众的知情权以及协调商业秘密权和知情权之间的冲突,具有一定的研究前景。笔者从权利保护角度出发,厘清药品信息的概念及特征,整理出问题的表现。着重研究信息的保密与公开问题,找到问题冲突背后的原因,基于此提出协调冲突的建议。本文从四个方面对这个问题进行分析:第一个部分从理论概念出发,厘清药品信息的内涵、外延及特征,对需要保护的药品信息范畴进行认定;第二部分列举了我国药品信息保护现状及存在的问题;第三部分对我国药品信息保护存在的问题进行原因分析;第四部分作为主要章节,对完善我国药品信息保护提出几点建议。
[Abstract]:With the successful entry into WTO and the coming of knowledge economy era, our country pays more attention to intellectual property. More and more attention has been paid to the protection of intellectual property in the field of medicine. The vigorous rise of pharmaceutical manufacturing enterprises can not be separated from the information protection of drugs. The relevant laws and regulations on the protection of drug information in our country are not perfect. It is not only beneficial to protect public health but also conducive to the maintenance of subsequent innovation to bring the right to know about public life and health into the scope of research on trade secrets. How to analyze the protection of drug information from the angle of right while pursuing the industrialization of drugs has a certain research prospect for protecting the public's right to know and coordinating the conflict between the right to know and the right to know. From the perspective of right protection, the author clarifies the concept and characteristics of drug information and sorts out the problems. This paper focuses on the confidentiality and disclosure of information, finds out the reasons behind the conflict, and puts forward some suggestions to coordinate the conflict. This paper analyzes this problem from four aspects: the first part is to clarify the connotation, extension and characteristics of drug information from the theoretical concept, and to identify the categories of drug information that need to be protected; The second part lists the current situation and existing problems of drug information protection in China; the third part analyzes the causes of the problems existing in the protection of drug information in China; the fourth part as the main chapter, Some suggestions are put forward to improve the protection of drug information in China.
【学位授予单位】：南昌大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：D922.16

【参考文献】